Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-004299

Options or other derivatives

  • EVP, Drug Development acquired 149,365 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
MANHARD KIMBERLY EVP, Drug Development 2023-01-18 Grant or award · Performance Stock Units +149,365 149,365 D
Loading xslF345X03/doc4.xml…